News Preview

Beyond Ozempic? New Weight Loss Drug Shows Stunning Results in Major Clinical Trial

Retatrutide, a new weight loss drug, has shown promising results in a major clinical trial. The weekly injection helped adults with excess weight and type 2 diabetes lose nearly a fifth of their starting weight on average, over 80 weeks. The trial also showed improved blood sugar control, but with more side effects like nausea and diarrhea.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.